Familial Mediterranean Fever
What's New
Last Posted: Oct 17, 2023
- Effectiveness of Colchicine or Canakinumab in Japanese Patients with Familial Mediterranean Fever: A Single-Center Study.
Shuhei Yoshida et al. J Clin Med 2023 12(19) - The Clinical Journey of a Patient with Familial Mediterranean Fever: One Gene, Three Diseases.
Pinar Ozge Avar-Aydin et al. Klinische Padiatrie 2023 - MEFV gene mutation spectrum in patients with familial mediterranean fever.
Hsin-Hui Wang et al. Pediatrics and neonatology 2023 - Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF.
Pinchevski-Kadir Shiran et al. Pediatric rheumatology online journal 2023 21(1) 4 - Colchicine treatment can be discontinued in a selected group of pediatric FMF patients.
Cohen Keren et al. Pediatric rheumatology online journal 2023 21(1) 2 - Diagnostic and therapeutic algorithms for monogenic autoinflammatory diseases presenting with recurrent fevers among adults.
Delplanque Marion et al. Rheumatology (Oxford, England) 2022 - The effect of a 18 bp deletion/insertion variant of VEGF gene on the FMF development.
Sezer Ozlem et al. Nucleosides, nucleotides & nucleic acids 2022 1-12 - Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Henes Joerg C et al. Journal of clinical medicine 2022 11(18) - Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.
Arnold Dennis D et al. Frontiers in immunology 2022 13888392 - The Characteristics of Pediatric Patients with Familial Mediterranean Fever Treated with Anti-Interleukin-1 Treatment.
Avar Aydin Pinar Özge et al. Turkish archives of pediatrics 2022 57(4) 448-452
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: